Though mice lacking TPL2 exhibited normal NFκB signaling, they revealed attenuated colitis severity accompanied by reduced levels of pro-inflammatory cytokines, suggesting that the observed anti-inflammatory effects are likely to be mediated via MAPK-signaling rather than NFκB signaling [9]. This evidence concerns the gene NFKB1 and colitis.